Product Information
MESALAMINE 1,000 MG SUPP is a generic product labeled by Actavis Pharma, Inc., priced at $1.3289 per EA under NDC 00472191530. Its NADAC has been published 263 times since Jun 16, 2021.
Strength
1000 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00472191530
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA205654On Market Since
4/23/2021
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE 1,000 MG SUPP has been published 263 times since Jun 16, 2021, and over the history we have for it it has declined 66.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3289 per EA |
|---|---|
| All-time high | $4.2619 (Aug 11, 2021) |
| All-time low | $1.2358 (Nov 20, 2024) |
| 52-week high | $1.6240 |
| 52-week low | $1.3289 |
| Median price | $1.8342 |
| Average price | $2.1572 |
| Largest weekly change | +47.4% (Nov 22, 2023) |
| Weeks tracked | 263 |
| Tracking since | Jun 16, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE 1,000 MG SUPP?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE 1,000 MG SUPP, manufactured by Actavis Pharma, Inc., is $1.3289 per EA (NDC 00472191530), effective Jun 24, 2026.
How has the price of MESALAMINE 1,000 MG SUPP changed over time?
Over the history we have for it, the NADAC for MESALAMINE 1,000 MG SUPP has declined 66.1%. It has been tracked across 263 weekly CMS publications since Jun 16, 2021.
What are the highest and lowest recorded NADAC prices for MESALAMINE 1,000 MG SUPP?
Since Jun 16, 2021, the NADAC for MESALAMINE 1,000 MG SUPP has ranged from a low of $1.2358 (Nov 20, 2024) to a high of $4.2619 (Aug 11, 2021), with a median of $1.8342 per EA.
Are there cheaper alternatives to MESALAMINE 1,000 MG SUPP?
6 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE 1,000 MG SUPP, but none are currently priced below it.
Who manufactures MESALAMINE 1,000 MG SUPP?
MESALAMINE 1,000 MG SUPP (NDC 00472191530) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification